Technological advances have led to the development of state-of-the-art systems and equipment that improve the efficiency and accuracy of infectious immunology, virology and bacteriology tests. Automated platforms enable rapid analysis of large sample volumes and provide reliable results within a very short time. The integration of robotics, artificial intelligence and machine learning enables precise identification of infectious agents and prediction of resistance patterns.
A significant advance in microbiological diagnostics are multiplex tests that can simultaneously detect multiple pathogens in a sample. These tests enable a comprehensive diagnosis and shorten the time to treatment. By using specific probes and reagents, viruses, bacteria and immunological markers can be identified simultaneously. This leads to faster and more accurate treatment of infectious diseases.
Another significant advance is point-of-care testing (POCT), which can be performed directly at the point of patient care. These portable devices enable rapid diagnosis of infections without having to send samples to a central laboratory for analysis. Doctors and medical staff can make immediate treatment decisions, which is especially beneficial in emergencies and remote areas. These tests are user-friendly, cost-effective and provide reliable results in a very short time.
The importance of advanced diagnostics: Advances in infection immunology, virology and bacteriology tests have had a significant impact on microbiological diagnostics. The rapid and accurate identification of infectious agents enables targeted treatment and reduces the risk of antibiotic resistance.
Crumlin,
United Kingdom of Great Britain and Northern Ireland
BBI Solutions has been serving the global diagnostics industry for over 30 years and is the world’s largest independent producer of immuno-diagnostics reagents. Our core competencies
BioAssay Works (BAW) focuses on rapid lateral flow assays. We deliver tailored contract assay development and manufacturing services, reagents and gold sol products that transform your ideas into
Biosynth is a supplier of critical materials, securing life science supply chains with global research, manufacturing, and distribution facilities. Supplying the pharmaceutical, vaccine and
BioVendor Group (BioVendor LM, BioVendor R&D, TestLine, ViennaLab, DIASource, BioVendor MDx), focusing on the development, production and distribution of immunodiagnostic and molecular diagnostic
A privately owned company/manufacturer, founded in 1996 in Milan Italy, with over 30 years of International experience & expertise in the field of Immuno Diagnostics for infectious diseases. Our
DIANA Biotechnologies is a Czech biotechnology company with strong in-house research and development. The company was founded in 2018 with the aim of developing applications of the patented DIANA
Epitope Diagnostics develops and manufactures innovative immunodiagnostic kits (CLIA, ELISA, Rapid Test) for the IVD community worldwide. Heavily invested in research and development of novel tests
ingenetix GmbH is an Austrian biotech company specializing in molecular biological test systems. Our field of expertise includes the development and production of real-time PCR-based tests for the
J. MITRA & CO. is a leading manufacturer & Exporter of Invitro Diagnostic Testing Solutions, incorporated in 1969. We have a wide manufacturing base comprising RAPIDs, ELISAs & Blood
LRE Medical GmbH is an internationally renowned service provider for contract development and manufacturing of medical/diagnostic and analytical devices from feasibility study to series production.